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Objective: Poststernotomy mediastinitis, although infrequent, is a potentially life-
threatening complication of cardiac surgery that continues to have a significant
morbidity and mortality despite aggressive therapy. Vacuum-assisted closure uses
controlled suction to provide evacuation of wound fluid, decrease bacterial coloni-
zation, stimulate granulation tissue, and reduce the need for dressing changes.
Methods: One hundred two patients from Duke University Hospital, The Durham
Veterans Administration Hospital, and referring institutions underwent vacuum-
assisted closure treatment. There were 63 men and 39 women, with a mean age of
67. The infection was noticed between postoperative days 8 and 34, at which time
the wounds were opened and debrided.
Results: Ninety-six of the 102 patients received vacuum-assisted therapy while the
remaining 6 underwent daily multiple dressing changes without vacuum-assisted
therapy. Fifty-three of the 96 patients required only sternal debridement, followed
by wound vacuum therapy and closure by secondary intention, while the remaining
43 had an additional procedure. Of these, 33 patients underwent omental transpo-
sition and 10 patients had a pectoralis flap. The length of stay for all patients was
27  12 days. This was related in part to intravenous antibiotics. Hospital mortality
for all patients was 3.7% (4 patients). Two of these patients underwent vascular flap
and succumbed to multisystemic organ failure, while the other 2 received only
wound vacuum therapy following debridement and succumbed to overwhelming
sepsis.
Conclusion: Vacuum-assisted drainage is an effective therapy for mediastinitis
following debribement or before placement of a vascularized tissue flap.
Poststernotomy mediastinitis is an infrequent but potentially devastat-ing complication after cardiac surgery. Reported incidences varybetween 0.5% and 10%, with an attendant mortality between 10% and20%.1 This disparity is dependent on preoperative predictors, whichinclude obesity, congestive heart failure, previous heart surgery, andduration of cardiopulmonary bypass.2 Treatment algorithms have
evolved in an effort to reduce the mortality and the morbidity associated with
mediastinitis. These include early aggressive debridement followed by either a
pectoralis flap or an omental transposition.
The vacuum-assisted closure (VAC) technique evolved from a desire to develop
a treatment for chronic debilitating wounds and was first described by Morykwas
and colleagues in 1997.3 This device is currently indicated for chronic wounds such
as stage III and IV pressure ulcers, along with venous, arterial, and neuropathic
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ulcers. Only recently has its use been expanded to the
treatment of poststernotomy mediastinitis. The VAC device
applies controlled suction to the wound, thereby increasing
local blood perfusion, accelerating the rate of granulation
tissue formation, decreasing tissue bacterial levels, and re-
ducing the need for dressing changes.4 Studies have docu-
mented the effectiveness of the VAC device in the treatment
of patients with poststernotomy mediastinitis, but these re-
sults have been limited to either case reports or small
studies.5-7
In the present study, the effectiveness of the VAC system
was evaluated as either an adjunct to conventional therapy
(debridement and vascular flap) or as sole therapy (debride-
ment plus VAC placement) for patients with post–cardiac
surgery mediastinitis.
Patients and Methods
Between 1997 and 2002, 102 patients from Duke University Hos-
pital, The Durham Veteran Administration Hospital, and referring
institutions (both in and out of state) underwent treatment of
poststernotomy mediastinitis. Data obtained from medical records
included demographic information (age, sex, race, weight), time
interval to mediastinitis presentation, prior operative procedures,
wound VAC application, hospitalization stay, mediastinal inter-
vention, and mortality. Culture results of infected median sternot-
omies were also reviewed. Length of stay was calculated after the
onset of mediastinitis if it occurred during the same hospitalization
as the initial cardiac surgery or the hospitalization from a separate
mediastinitis admission. The Duke Institutional Review Board
approved the data collection methods.
At the time of presentation, the sternal wound was debrided of
foreign material and necrotic tissue and the wound vacuum device
was applied. Patients with superficial wound infections or fat
necrosis were not included in this study. The decision to use a
vascular flap was not made until after a 5- to 7-day interval of
wound vacuum therapy. Only patients who had a deep sternal
infection requiring removal of all wires had to undergo an addi-
tional vascular flap procedure. The decision to proceed to either an
omental flap or a pectoralis flap was made based on surgeon’s
preference.
Results
One hundred two patients underwent treatment of postster-
notomy mediastinitis. There were 63 men and 39 women,
with an average age of 67 years. Mediastinal infection was
detected between 8 and 34 days after the initial cardiac
procedure. Hospitalization resulting from mediastinitis was
27  12 days (Table 1). Treatment of the 102 patients with
poststernotomy mediastinitis (Figure 1) consisted of de-
bridement, with a combination of dressing changes and/or
VAC application (specifically, reconstructive procedures
with either omental transposition or a pectoralis flap). Six
patients did not receive wound vacuum therapy; instead
they were treated with multiple wet to dry dressing changes.
These 6 patients were seen early during the examined time
interval, when the use of the vacuum device was still
limited. Of the 96 patients who did receive wound vacuum
therapy, 43 had additional procedures. Of these patients, 33
received omental transposition and 10 received a pectoralis
flap, while the remaining 53 required only wound debride-
ment and were allowed secondary closure with a vacuum-
assisted therapy device already in place.
There were 4 deaths (3.7%). Two of these patients un-
derwent vascular flap procedures (1 omental transposition
and 1 pectoral flap) and death was attributed to multisys-
temic organ failure. The other 2 received only wound vac-
uum therapy after debridement and succumbed to over-
whelming sepsis, related in part to delayed referrals to our
institution.
Discussion
Poststernotomy mediastinitis, albeit infrequent, is a dreaded
complication. Numerous studies have reported an increase
in morbidity and mortality, as well as a decreased long-term
survival, after an initial successful treatment. In addition, it
is financially costly to the health care system because of
increased hospitalization, additional procedures, and incum-
bent nursing care. The treatment of poststernotomy medi-
astinitis has evolved since 1969, when Payne and Larson8
described the technique of wound debridement, primary
sternal closure, and closed mediastinal catheter irrigation.
This was followed in the early 1980s by the use of muscle
flaps to fill dead space in the mediastinum and to cover the
traumatized sternum.1 Myocutaneous flaps have allowed
early closure and healing of sternal wounds; however, the
mortality rate associated with mediastinitis remains between
10% and 20%.1 VAC emerged in 1997 as first described by
Morykwas and Argenta3 and can be regarded as a method
that combines the benefits of both closed and open wound
treatment. Animal studies performed by Morykwas and
colleagues showed that the application of subatmospheric
pressure increased blood flow, increased rates of granulation
tissue formation, and decreased tissue bacterial counts.3
Specifically, laser Doppler flow increased by 4 times com-
pared with baseline, while tissue bacterial counts decreased
by 21% versus control wounds treated at ambient pressure.
The VAC technique has many advantages including the
stimulation of granulation tissue that may make secondary
closure with a myocutaneous flap unnecessary. It also clears
TABLE 1. Patient characteristics
Mean age (y) 67
Sex
Male 63
Female 39
Infection detected (postoperative days) 8-34
Length of hospitalization stay (days) 27  12
Mortality 3.7%
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away secretions and toxic products by continuous suction,
thus preventing fluid retention in the depth of the wound.
This is accomplished with the creation of a mild negative
atmospheric environment (125 mm Hg). Currently the use
of intermittent suction is also being investigated. In addi-
tion, the polyurethane foam used in vacuum therapy only
requires changing every 2 days, unlike the twice-daily
changes needed in traditional wound dressings. Some pa-
tients are also able to go home with the wound vacuum in
place by using a battery-operated portable suction device.
The clinical application of vacuum treatment for post-
sternotomy mediastinitis has been studied in 3 small series.
Mendez-Eastman4,6 documented a case study of a 55-year-
old woman who was readmitted for treatment of an infected
sternal wound 11 days after coronary artery bypass grafting.
The management of this patient included surgical incision
and drainage of the sternum, sternectomy, and pectoralis
and rectus abdominus muscle flaps. After the wound re-
opened, this patient then received hyperbaric oxygen treat-
ment and VAC was applied to sternum. These additional
techniques served as important complementary treatments
essential to the healing process. Unlike the patient in this
case report, the majority of the patients in our study under-
went debridement and wound VAC therapy before a vas-
cular flap procedure. Obdeijn and colleagues7 conducted a
slightly larger study of 3 patients with poststernotomy me-
diastinitis who were treated with VAC. This study showed
that the VAC applied to all patients made it possible to
avoid the need for surgical closure with a vascularized
muscle flap. In addition, no complications in wound healing
were seen at a mean follow-up of 20 months. A study of 15
patients with poststernotomy mediastinitis treated with
wound vacuum therapy was conducted by Tang and col-
leagues,9 who reported patients with varying severity of
sternotomy wound infection. They reported complete
wound healing in all survivors, including 3 who had sternal
dehiscence infected by methicillin-resistant Staphylococcus
aureus (MRSA). In addition, skin grafting was needed in 2
patients who had sternal dehiscence with mediastinitis. Berg
and colleagues10 performed a retrospective analysis of pa-
tients with mediastinitis, comparing treatment with either a
wound vacuum system or continuous irrigation. They found
that the closed drainage system using a wound vacuum
resulted in fewer treatment failures and a shorter stay in the
hospital.
In a retrospective review of 72 patients with mediastini-
tis, Kirsh and colleagues11 used a closed drainage system
with multiperforated rigid tubes (Redon drainage system) to
evacuate the mediastinum. A mortality rate of approxi-
mately 35% was observed. This high number was in part
attributed to the presence of MRSA in the culture medium.
This type of closed drainage system varies significantly
from the methods used in our study. The methods used by
these authors created a strong negative pressure within the
mediastinum (700 mm Hg). The pressure typically treated
with wound VAC systems is 50 to 100 mm Hg. It is unclear
whether this degree of negative pressure was detrimental to
the patients. A recently study by Gustafsson and col-
leagues12 reported the novel use of monitoring plasma C-
reactive protein levels in guiding the VAC system. They
reported 16 patients who had deep sternal infections at no
mortality at 3 months after surgery.12
In the current study, the wound vacuum was used in
patients who had either superficial sternal wounds (but not
superficial wound infection; ie, above the sternal fascia) that
did not necessitate removal of the wires and also in those
patients who had a full sternal infection requiring removal
of the wires. Patients underwent an additional procedure of
either an omental transposition or a pectoralis flap. Milano
and colleagues13 reported that those patients receiving an
omental flap had both a shorter hospital stay and fewer early
complications.13 Although we did not evaluate the data to
Figure 1. Surgical and VAC treatment of poststernotomy mediastinitis. VAC, Vacuum-assisted closure.
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determine if this difference existed in our group of patients,
of those patients requiring a flap the majority did receive an
omental transposition.
The results of these studies, although limited by the small
number of patients evaluated, illustrate that vacuum therapy
is an important treatment tool for the thoracic surgeon faced
with poststernotomy mediastinitis. Moreover, its use also
decreases the need for additional surgical reconstruction
with vascularized flaps. The results from our study of 102
patients support these findings. Vacuum therapy proved to
be an important adjunct to the treatment of poststernotomy
mediastinitis. The overall incidence of poststernotomy me-
diastinitis at our institution is between 1% and 1.5%. The
wound vacuum system can be used either in combination
with a vascular flap or as a primary therapy following
debridement, which in turn allows secondary healing to
proceed. The depth of the sternal infection influences the
role of the wound vacuum, as either sole therapy for more
superficial wounds or as adjuvant therapy for deeper
wounds. Among those patients receiving vacuum therapy,
43 required vascularized flaps; however, 53 required no
additional procedures except for wound debridement and
secondary closure with the VAC system. Although a con-
trolled randomized study would be necessary to determine if
the wound vacuum device significantly lowered mortality
and morbidity compared with historical treatment modali-
ties, the data from this study support the role of the wound
vacuum not only as an effective treatment tool but also to
significantly lower overall mortality.
In conclusion, VAC is a useful asset in the treatment of
poststernotomy mediastinitis. It may be used effectively
before primary closure or as a preparation for secondary
closure with vascularized tissue.
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Discussion
Dr James W. Long (Salt Lake City, Utah). Dr Wolfe, you and
your colleagues have made some very important contributions
with a novel therapy. First, this is clearly the largest experience
with vacuum-assisted closure for mediastinitis, 96 patients, and
before this 15 maximum. Second, your mortality outcomes in this
series are quite impressive at 3.7%. Third, 55% of your patients
were able to get by without vascular flap reconstruction. Obviously
there are some important things that have been learned here. There
are some challenges that are left, one of which that is not entirely
clear from this paper is what role vacuum-assisted closure may be
contributing. Your study design is primarily observational, with no
statistically useful control group. You have a second group of
small sample size, 6 patients, but not really characterized very
well. One has to consider the possibility that your improved
outcomes may not be due entirely vacuum-assisted closure. Cer-
tainly before this therapy results have been progressively improv-
ing. Even in your own institution in 1996 there was a 29%
incidence of mediastinitis and by 1999 it is reduced to 10.5% when
you used pectoralis flaps, and down to 4.8% with omental flaps
without this therapy, quite close to the mortality results you had
with this therapy. In the absence of a formal control group, we are
not given a lot of information, either, to help us judge this histor-
ically. The question I have for you is: Do you believe that vacuum-
assisted closure therapy has been responsible for your improved
mortality?
Dr Domkowski. Thank you, Dr Long, for reviewing our paper
and for your comments and question. You are right, it is an
observational and a retrospective analysis of vacuum-assisted clo-
sure. The way to do it would be a prospective trial in which we
would randomize patients either to traditional treatment followed
by vascular flap therapy if it were appropriate versus vacuum-
assisted. However, as this has been introduced to our institution,
and obviously there is some bias involved, Dr Wolfe and I were
very impressed with their initial results of vacuum-assisted ther-
apy. In a significant number of patients, it has reduced the need for
a second intervention (ie, omental or pectoral flap). We do believe
that the use of this device is in large part responsible for the
reduction in mortality. I think it is important to remember that the
additional benefit, while it does reduce mortality, also saved many
patients from an additional procedure, because with debridement
in the operating room, with the infection going down to the bone,
sometimes the wires would need to be tightened or a few taken out
and then the vacuum-assisted device put in place. It is really quite
remarkable that the physiology behind this vacuum does promote
stimulation of granulation tissue, at least subjectively, again, to be
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